(Q57109395)

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

The incidence, importance, and prophylaxis of acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Rales, peripheral edema, retinal hemorrhage and acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Altitude Illness Among Tourists Flying to 3740 Meters Elevation in the Nepal Himalayas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High-altitude pulmonary edema at moderate altitude (< 2,400 m; 7,870 feet): a series of 52 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Exercise exacerbates acute mountain sickness at simulated high altitude

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Children at high altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Neck irradiation or surgery may predispose to severe acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Inflammatory processes may predispose children to high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Medical problems of porters and trekkers in the Nepal Himalaya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Clinical features of headache at altitude: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Acute medical problems in the Himalayas outside the setting of altitude sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

The cerebral etiology of high-altitude cerebral edema and acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Low acute hypoxic ventilatory response and hypoxic depression in acute altitude sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Low pulmonary diffusing capacity in subjects with acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Cerebral form of high-altitude illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

1 reference

7 January 2021

Role of veins and cerebral venous pressure in disruption of the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Mediators of cerebral edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Plasma vascular endothelial growth factor in acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Effects of high-altitude exposure on vascular endothelial growth factor levels in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Dexamethasone in the treatment of acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Volumetric quantification of brain swelling after hypobaric hypoxia exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Suddenly symptomatic brain tumors at altitude

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Subarachnoid cyst and ascent to high altitude--a problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Sumatriptan for high-altitude headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Ibuprofen versus sumatriptan for high-altitude headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Fluid retention and relative hypoventilation in acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Effect of acetazolamide on acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Nocturnal periodic breathing and the development of acute high altitude illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

The random nature of cerebral mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High-Altitude Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Prevention of acute mountain sickness by dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Treatment of acute mountain sickness: hyperbaric versus oxygen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Treatment of acute mountain sickness by simulated descent: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High-altitude pulmonary edema in persons without the right pulmonary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High-altitude pulmonary edema with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Variable radiomorphologic data of high altitude pulmonary edema. Features from 60 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Nifedipine for high altitude pulmonary oedema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Prevention of high-altitude pulmonary edema by nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Inhaled nitric oxide for high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High-altitude pulmonary edema is initially caused by an increase in capillary pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High-altitude pulmonary edema: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Exaggerated endothelin release in high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

The lung at high altitude: bronchoalveolar lavage in acute mountain sickness and pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Cytokines in bronchoalveolar lavage fluid in patients with high altitude pulmonary oedema at moderate altitude in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Association of high-altitude pulmonary edema with the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Endothelial selectins in acute mountain sickness and high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Evidence against an increase in capillary permeability in subjects exposed to high altitude

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Coagulation and fibrinolysis in acute mountain sickness and beginning pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Urinary leukotriene E(4) levels are not increased prior to high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Transepithelial sodium and water transport in the lung. Major player and novel therapeutic target in pulmonary edema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Salmeterol for the prevention of high-altitude pulmonary edema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Alveolar liquid and protein clearance from normal dog lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High altitude pulmonary edema is caused by stress failure of pulmonary capillaries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Ultrastructural appearances of pulmonary capillaries at high transmural pressures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Protein, cell, and LTB4 concentrations of lung edema fluid produced by high capillary pressures in rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

High-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Angiotensin-converting enzyme and genetics at high altitude

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

No association between high-altitude tolerance and the ACE I/D gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021

Sildenafil inhibits hypoxia-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913591-X

7 January 2021